Comparison of Respiratory Muscle, Pain, Functional Performance and Cognitive Status in Obstructive Lung Diseases

Assessment of Cognitive Status, Pain, Functional Status, Postural Awareness, Respiratory Muscle Strength and Endurance in Obstructive Pulmonary Diseases

In the literature, there are a limited number of studies evaluating postural awareness, cognitive status, respiratory muscle strength and endurance, functional capacity, and pain in people with obstructive pulmonary disease, and comparing these parameters with each other and with healthy subjects, and most of the studies are on chronic obstructive pulmonary disease patients. There we will evaluate these parameters in different obstructive lung diseases and compare the findings of healthy individuals.

Study Overview

• Status: Completed
• Conditions: Cognitive Impairment; Pain, Chronic; Obstructive Pulmonary Disease; Functional Disturbance

• Study Type: Observational
• Enrollment (Actual): 63

Contacts and Locations

Study Locations

• Turkey
  • Please Choose A State
    • Ankara, Please Choose A State, Turkey, 06100
      • Hacettepe University Faculty of Health Sciences Department of Physiotherapy and Rehabilitation

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years to 65 years (Adult, Older Adult)
• Accepts Healthy Volunteers: No
• Genders Eligible for Study: All

• Sampling Method: Probability Sample

Study Population

Obstructive lung diseases in 18-65 years old

Description

Inclusion Criteria for obstructive lung diseases

1. To be diagnosed with obstructive pulmonary disease,
2. Have not experienced acute exacerbation in the last 3 months,
3. Being between the ages of 18-65,
4. Not having chronic pain problems,
5. Volunteer for research,
6. To be able to walk and cooperate.

Exclusion criteria for obstructive lung diseases

1. To be able to diagnose neurological disorder,
2. To have an advanced orthopedic disease that may affect functional capacity measurement.

Criteria for Non-Inclusion for healthy group

1. To have any cardiopulmonary disease,
2. To have an advanced orthopedic disease that may affect functional capacity measurement.

Study Plan

How is the study designed?

Design Details

• Observational Models: Case-Control
• Time Perspectives: Prospective

Number of groups / cohorts

2

Cohorts and Interventions

Group / Cohort
Obstructive lung diseases group
Healthy group

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Pain Perception	Pain Perception Threshold and Tolerance With Algometer	01.01.2019-31.08.2019

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Cognitive Function Assessment	Montreal Cognitive Assessment Test (MoCA)	01.01.2019-31.08.2019
Functional capacity assesment	6 minute walk test	01.01.2019-31.08.2019
Postural awareness assesment	Body Awareness Questionnare is a likert type questionnare and total score ranges from 18-126. Higher scores mean better body awareness level	01.01.2019-31.08.2019
Respiratory muscle strength and endurance measurement	Mouth pressure measurement	01.01.2019-31.08.2019

Collaborators and Investigators

• Sponsor: Hacettepe University
• Investigators: Principal Investigator: Ebru Calik Kutukcu, PhD, Hacettepe University; Principal Investigator: Melda Saglam, PhD, Hacettepe University; Principal Investigator: Deniz Inal Ince, Professor, Hacettepe University; Principal Investigator: Hulya Arikan, Professor, Hacettepe University; Study Director: Naciye Vardar Yagli, PhD, Hacettepe University

Study record dates

Study Major Dates

• Study Start (Actual): January 1, 2019
• Primary Completion (Actual): June 24, 2020
• Study Completion (Actual): June 24, 2020

Study Registration Dates

• First Submitted: August 6, 2019
• First Submitted That Met QC Criteria: August 6, 2019
• First Posted (Actual): August 7, 2019

Study Record Updates

• Last Update Posted (Actual): July 29, 2020
• Last Update Submitted That Met QC Criteria: July 28, 2020
• Last Verified: July 1, 2020

More Information

Terms related to this study

• Additional Relevant MeSH Terms: Respiratory Tract Diseases; Pain; Neurologic Manifestations; Lung Diseases; Lung Diseases, Obstructive; Chronic Pain
• Other Study ID Numbers: GO 18/109

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: No

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No